loadpatents
Patent applications and USPTO patent grants for Barasch; Jonathan.The latest application filed is for "mutant ngal proteins and uses thereof".
Patent | Date |
---|---|
Methods of treating volume depletion and kidney injury Grant 11,119,104 - Barasch , et al. September 14, 2 | 2021-09-14 |
Mutant Ngal Proteins And Uses Thereof App 20210038686 - BARASCH; Jonathan ;   et al. | 2021-02-11 |
Mutant NGAL proteins and uses thereof Grant 10,829,525 - Barasch , et al. November 10, 2 | 2020-11-10 |
Mutant NGAL proteins and uses thereof Grant 10,588,937 - Barasch , et al. | 2020-03-17 |
Methods Of Treating Volume Depletion And Kidney Injury App 20190064166 - BARASCH; Jonathan ;   et al. | 2019-02-28 |
Mutant Ngal Proteins And Uses Thereof App 20170189482 - BARASCH; Jonathan ;   et al. | 2017-07-06 |
Mutant Ngal Proteins And Uses Thereof App 20170190751 - BARASCH; Jonathan ;   et al. | 2017-07-06 |
Mutant NGAL proteins and uses thereof Grant 9,624,281 - Barasch , et al. April 18, 2 | 2017-04-18 |
Mutant NGAL proteins and uses thereof Grant 9,534,027 - Barasch , et al. January 3, 2 | 2017-01-03 |
Ngal And Urinary Tract Infection App 20160136237 - BARASCH; Jonathan ;   et al. | 2016-05-19 |
Mutant Ngal Proteins And Uses Thereof App 20150329607 - BARASCH; Jonathan ;   et al. | 2015-11-19 |
High molecular weight Ngal as a biomarker for chronic kidney disease Grant 8,592,170 - Barasch , et al. November 26, 2 | 2013-11-26 |
Use Of Urinary Ngal To Diagnose Unilateral And Bilateral Urinary Obstruction App 20130230870 - BARASCH; Jonathan ;   et al. | 2013-09-05 |
Mutant Ngal Proteins And Uses Thereof App 20130217637 - BARASCH; Jonathan ;   et al. | 2013-08-22 |
Ngal And Urinary Tract Infection App 20130157932 - BARASCH; Jonathan ;   et al. | 2013-06-20 |
Methods And Compositions For Diagnosis Of Urosepsis And Urinary Tract Infection App 20130149725 - BARASCH; Jonathan ;   et al. | 2013-06-13 |
Use Of Urinary Ngal To Diagnose Sepsis In Very Low Birth Weight Infants App 20130072580 - BARASCH; Jonathan ;   et al. | 2013-03-21 |
Methods And Compositions For Diagnosis Of Urosepsis And Urinary Tract Infection App 20120214177 - Barasch; Jonathan ;   et al. | 2012-08-23 |
Use Of Urinary Ngal To Diagnose And Monitor Hiv-associated Nephropathy (hivan) App 20120083421 - Barasch; Jonathan ;   et al. | 2012-04-05 |
Ngal-binding Siderophores And Use Thereof To Treat Iron Deficiency And Iron Overload App 20110268818 - Barasch; Jonathan ;   et al. | 2011-11-03 |
High Molecular Weight Ngal As A Biomarker For Chronic Kidney Disease App 20110091912 - Barasch; Jonathan ;   et al. | 2011-04-21 |
Use Of Urinary Ngal To Diagnose Unilateral And Bilateral Urinary Obstruction App 20100233739 - BARASCH; Jonathan ;   et al. | 2010-09-16 |
Use Of Urinary Ngal To Distinguish Kidney Disease And Predict Mortality In Subjects With Cirrhosis App 20100233740 - BARASCH; Jonathan ;   et al. | 2010-09-16 |
Lipocalin 2 for the Treatment, Prevention, and Management of Cancer Metastasis, Angiogenesis, and Fibrosis App 20090305963 - Sukhatme; Vikas P. ;   et al. | 2009-12-10 |
Compositions for modulating growth of embryonic and adult kidney tissue and uses for treating kidney damage App 20080090765 - Schmidt-Ott; Kai ;   et al. | 2008-04-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.